| Literature DB >> 28198391 |
Annalisa Vetro1, Salvatore Savasta2, Annalisa Russo Raucci1, Cristina Cerqua3,4, Geppo Sartori5, Ivan Limongelli6, Antonella Forlino7, Silvia Maruelli7, Paola Perucca1, Debora Vergani1, Giuliano Mazzini8, Andrea Mattevi9, Lucia Anna Stivala1, Leonardo Salviati3,4, Orsetta Zuffardi1.
Abstract
Meier-Gorlin syndrome (MGORS) is a rare disorder characterized by primordial dwarfism, microtia, and patellar aplasia/hypoplasia. Recessive mutations in ORC1, ORC4, ORC6, CDT1, CDC6, and CDC45, encoding members of the pre-replication (pre-RC) and pre-initiation (pre-IC) complexes, and heterozygous mutations in GMNN, a regulator of cell-cycle progression and DNA replication, have already been associated with this condition. We performed whole-exome sequencing (WES) in a patient with a clinical diagnosis of MGORS and identified biallelic variants in MCM5. This gene encodes a subunit of the replicative helicase complex, which represents a component of the pre-RC. Both variants, a missense substitution within a conserved domain critical for the helicase activity, and a single base deletion causing a frameshift and a premature stop codon, were predicted to be detrimental for the MCM5 function. Although variants of MCM5 have never been reported in specific human diseases, defect of this gene in zebrafish causes a phenotype of growth restriction overlapping the one associated with orc1 depletion. Complementation experiments in yeast showed that the plasmid carrying the missense variant was unable to rescue the lethal phenotype caused by mcm5 deletion. Moreover cell-cycle progression was delayed in patient's cells, as already shown for mutations in the ORC1 gene. Altogether our findings support the role of MCM5 as a novel gene involved in MGORS, further emphasizing that this condition is caused by impaired DNA replication.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28198391 PMCID: PMC5437912 DOI: 10.1038/ejhg.2017.5
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246